Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Mironid $46M Series BCellCentric $220M Series DRanked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Mironid $46M Series BCellCentric $220M Series DNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Olix $312M Series BRivan $34M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Qureight $20M Series BKord £6.4M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Agon $30M Pre-Seed+SeedCuspAI $450M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Qureight $20M Series BIMU Biosciences $53M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
Moa Technology £22.2M Series COxford Quantum Circuits £260M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Moa Technology £22.2M Series CRQ Bio $115M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
CuspAI $450M Series BAutomata $45M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Fleek $25M Series BNoah $38M Seed, final close October 2026New companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
TaiSan £4.7M SeedNEX Health Intelligence €1M Pre-SeedNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
TaiSan £4.7M SeedNEX Health Intelligence €1M Pre-SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TaiSan £4.7M SeedNami Surgical £1.9M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Gaussion $28M Funding roundParaglide $5M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Gaussion $28M Funding roundGigaton $26M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TRIMTECH Therapeutics $47M Seed+Lightcast $27M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TRIMTECH Therapeutics $47M Seed+Semarion $3.8M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Conduct $60M Series ASwap $100M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Gradient Labs $13M Series AArtificial Labs $45M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.